CSER RoRC Centralized Support Coordinating Center
Institution: University of Washington
FOA Number: PA-12-100
Abstract
The Clinical Sequencing Exploratory Research (CSER) and Return of Results Consortium (RoRC) programs are designed to investigate critical questions about the application of genomic sequencing to clinical care of individual patients, from generation of genomic sequence data, to interpretation and translation of the data for the physician, to communication to the patient, including an examination of the ethical and psychosocial implications of bringing broad genomic data into the clinic. The goal of ELSI involvement in CSER is to support ELSI research required to responsibly apply personal genomic data to medical care, with a particular emphasis on the ethical, legal, and psychosocial implications of generating and returning genomic results, including returning incidental findings
CSER website: https://www.genome.gov/27546194/clinical-sequencing-exploratory-research/
FUNDING AGENCY:
Funder:
NIH
Institute:
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Funding Type:
U01
Project Number:
U01HG007307
Start Date:
Apr 1, 2013
End Date:
Mar 31, 2017
PROJECT TERMS:
Area; Bioethics; Bioinformatics; Biology; Caring; Cataloging; Catalogs; Clinical; Clinical Informatics; clinical practice; Clinical sequencing; Clinical Treatment; clinically actionable; Complex; Computerized Medical Record; cost; Data; data sharing; design; Development; Diagnosis; Discipline; Disease; DNA Resequencing; DNA Sequence; Effectiveness; Ensure; ethical legal social implication; exome sequencing; expectation; experience; Funding; Future; gene mutation; Genetic; Genetic Medicine; Genetic Structures; Genetic Variation; Genome; genome sequencing; Genomics; Goals; Healthcare; Hereditary Disease; High-Throughput DNA Sequencing; Human; human DNA; Human Genetics; Human Genome Project; improved; Individual; Informatics; Institutes; Internal Medicine; International; Knowledge; Leadership; Logistics; Medical; Medical Genetics; Medicine; member; Methods; Molecular Diagnostic Testing; National Heart, Lung, and Blood Institute; National Human Genome Research Institute; Neonatology; Outcome; Outcomes Research; Patients; Pediatric Neurology; Pharmacogenetics; pharmacogenomics; Physicians; Policies; Population; Positioning Attribute; programs; public health relevance; Recommendation; Reporting; Research; Science; Sequence Analysis; success; Technology; Translating; United States National Institutes of Health; Universities; Variant; Washington; Work; working group